The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerdan, C.
Right arrow Articles by Olive, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerdan, C.
Right arrow Articles by Olive, D.

The Journal of Immunology, Vol 146, Issue 2 560-564, Copyright © 1991 by American Association of Immunologists


ARTICLES

IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways

C Cerdan, Y Martin, H Brailly, M Courcoul, S Flavetta, R Costello, C Mawas, F Birg and D Olive
Unite 119 de l'INSERM, 27, Marseille, France.

In addition to activation via the TCR complex, resting purified T cells can be activated to proliferate by mAb directed against the two surface molecules, CD2 and CD28. We demonstrate here that only the CD2 plus CD28 combined activation induces the expression and secretion of IL-1 alpha, a cytokine classically considered as a monokine. In contrast, neither IL-1 beta nor IL-6 were produced. A second monokine, TNF-alpha was transiently expressed by T cells activated with either CD2 or CD28 mAb, but was expressed to higher levels and with a prolonged kinetics in cells activated by the CD2 plus CD28 combination. The prolonged expression of the IL-1 alpha gene could account, at least in part, for the monocyte-independent and long lasting T cell proliferation induced by the CD2 plus CD28 co-stimulation. Secretion of monokines, such as IL- 1 alpha, by activated T cells, could play a regulatory role in immune responses, as well as contribute to autoimmune processes.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J.-P. Bayley, J. G. I. van Rietschoten, A. M. Bakker, L. van Baarsen, E. L. Kaijzel, E. A. Wierenga, T. C. T. M. van der Pouw Kraan, T. W. J. Huizinga, and C. L. Verweij
Allele-Specific Expression of the IL-1{alpha} Gene in Human CD4+ T Cell Clones
J. Immunol., September 1, 2003; 171(5): 2349 - 2353.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-H. Yeh, P. Lecine, J. A. Nunes, S. Spicuglia, P. Ferrier, D. Olive, and J. Imbert
Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor {alpha}-Chain Locus
Mol. Cell. Biol., July 15, 2001; 21(14): 4515 - 4527.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Yarwood, J. C. Mason, D. Mahiouz, K. Sugars, and D. O. Haskard
Resting and activated T cells induce expression of E-selectin and VCAM-1 by vascular endothelial cells through a contact-dependent but CD40 ligand-independent mechanism
J. Leukoc. Biol., August 1, 2000; 68(2): 233 - 242.
[Abstract] [Full Text]


Home page
BloodHome page
F. Roufosse, L. Schandene, C. Sibille, B. Kennes, A. Efira, E. Cogan, and M. Goldman
T-Cell Receptor-Independent Activation of Clonal Th2 Cells Associated With Chronic Hypereosinophilia
Blood, August 1, 1999; 94(3): 994 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Voronov, Y. Weinstein, D. Benharroch, E. Cagnano, R. Ofir, M. Dobkin, R. M. White, M. Zoller, V. Barak, S. Segal, et al.
Antitumor and Immunotherapeutic Effects of Activated Invasive T Lymphoma Cells That Display Short-Term Interleukin 1{{alpha}} Expression
Cancer Res., March 1, 1999; 59(5): 1029 - 1035.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.